5PSQ-053 Drug utilisation study of human normal immunoglobulin in haematological and oncologic patients in a teaching paediatric hospital

BACKGROUND: Approved therapeutic indications for human normal immunoglobulin (HNIg) in the paediatric population are: primary immunodeficiency syndromes, hypogammaglobulinaemia post-stem cell transplantation, AIDS with recurrent infections and primary immune thrombocytopenia (ITP), among others. Apa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Busquets, F Bossacoma, Genestar, JL Vinent, Llobet, A Ruiz, Passini, VP Celis, Pasqual, N Arranz, Comes, A, Suárez, J Arrojo, Celma, M Sácnhez
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 5: Patient safety and quality assurance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535465/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.407
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars